Table 1.
Pharmacodynamic effects of loperamide by co-administered drug
Period | Co-administered drug | Dose, mg | Number of subjects | AUEC of change in pupil diameter (mm*h) | AUEC of alertness score (VAS score*h) | AUEC of oxygen saturation (%*h) |
---|---|---|---|---|---|---|
1 | None | NA | 18 | −19.7 ± 26.7 | 944.7 ± 694.7 | 4684.5 ± 27.1 |
2 | Quinidine | 600 | 18 | −44.4 ± 35.3† | 945.7 ± 619.2 | 4698.9 ± 31.5† |
3 | HM30181 | 15 | 6 | −24.2 ± 32.3 | 767.8 ± 309.5 | 4711.9 ± 20.6 |
60 | 6 | 1.4 ± 13.4 | 794.6 ± 832.8 | 4713.0 ± 24.3 | ||
180 | 6 | −11.4 ± 13.2 | 1166.0 ± 701.9 | 4717.5 ± 39.2 | ||
All | 18 | −11.4 ± 23.0* | 909.4 ± 641.9 | 4714.1 ± 27.5*,† |
Data are mean ± SD. AUEC (the area under the effect–time curve),
P < 0.05 vs. quinidine co-administration;
P < 0.05 vs. loperamide alone.